RCM Technologies heads into its May 18 earnings report carrying the weight of a 20% single-day collapse — and a conspicuous pattern of insider selling that preceded it.
The insider story is the most striking feature of the setup. CFO Kevin Miller sold over $1 million in shares across a series of transactions in April and early May, all at prices around $32. Chairman and President Bradley Vizi sold nearly 50,000 shares on April 16 for roughly $1.5 million. In aggregate, insiders net-sold more than $4.5 million worth of stock over the past 90 days. The stock now trades at $23.12 — well below those exit prices — after RCMT released its Q1 10-Q on May 14 and the market sent shares down 20% in a single session.
Short sellers were not the force behind that move. Short interest is modest at roughly 2.8% of free float, having fallen nearly 14% over the past week. Availability in the lending pool is extremely loose — well above 1,000% of shares already borrowed — meaning shorting this stock has faced no structural constraint. Cost to borrow is negligible at 0.51%, up about 70% on the week in percentage terms but still less than a rounding error in absolute terms. The ORTEX short score of 40.6 sits in the lower half of the universe. Borrowed shares are not driving the price action here.
Benchmark's Bill Sutherland maintained a Buy rating in early April and lifted his target to $36, after the stock had surged 32% in a single day on April 3 following a separate announcement. That target now implies roughly 56% upside from current levels — a gap that reflects how sharply the May 14 selloff recalibrated the picture. The analyst consensus remains constructive, but coverage is thin and the last formal update pre-dates the Q1 release, leaving the Street's view materially stale relative to Friday's close.
The historical reaction pattern at RCMT is genuinely volatile in both directions. The April 3 announcement triggered a 32% one-day gain and a 40% five-day follow-through. The Q3 2025 print in November produced a 14% drop on the day and nearly 20% over five days. The Q1 2026 report released on May 14 — which appears to have been an early filing rather than a scheduled earnings call — already delivered its verdict with a 20% decline. Monday's May 18 event will test whether that reaction was a full repricing or merely the first leg of a reassessment.
See the live data behind this article on ORTEX.
Open RCMT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
